NEWS

July 22, 2020

Patent examination ongoing in Korea, USA, Europe, China, India etc.

Bukwang Pharmaceutical (“Bukwang”) announced that its...

June 30, 2020

Contera Pharma (“Contera”), subsidiary of Bukwang Pharmaceutical (“Bukwang”), announced 51 billion KRW Series B financin...

June 8, 2020

Midazolam export to Luxembourg and France completed, the United Kingdom and Chile under discussion

Bukwang announced that...

March 10, 2020

Levovir demonstrated comparable efficacy to KALETRA® against coronavirus in vitro

Bukwang Pharmaceutical Co., Ltd. announ...

February 14, 2020

- Contera Pharma is preparing for public offering in KOSDAQ -

Bukwang has recently received the investigational new drug...

January 31, 2020

- Kalbe International to take on sales in 2 approved countries

Bukwang Pharmaceutical Co., Ltd (Bukwang) announced that i...

January 10, 2020

Bukwang Pharmaceutical Co., Ltd. (Bukwang) announced that JM-010 has been administered to the first patient in phase 2 s...

January 2, 2020

Bukwang Pharmaceutical announced that it has entered into an agreement with Sanofi-Aventis Korea to co-promote an ARB cl...

November 13, 2019

ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor based therapies for neurodegenerative diseas...

September 30, 2019

ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUAHR Therapeutics with Bukwang investing up...

Please reload

Recent
Please reload

|    ​Korean    |

7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square